First human tests begin for new Vision-Saving eye injection
NCT ID NCT07425522
Summary
This is an early-stage study to check the safety and how the body handles a new drug called RO7823653 for diabetic macular edema (DME), a cause of vision loss. About 93 people with DME will receive injections of the new drug into the eye, either by itself or alongside an existing drug called faricimab. The main goal is to see what side effects occur and to find a safe dose for future testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.